H.R. 6094 · 118th Congress
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
26 cosponsors · 18 D, 8 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act
What it does: CRS summary · Introduced in House · Oct 26, 2023
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act
This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Oct 26, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.